Results 331 to 340 of about 216,439 (378)

KF1601, a dual inhibitor of BCR::ABL1 and FLT3, overcomes drug resistance in FLT3⁺ blast phase chronic myeloid leukemia. [PDF]

Mol Cancer
Kwon HJ, Shin JE, Khan A, Park SY, Kim J, Lee JY, Lee D, Lee S, Im CY, Moon H, Han YR, Tamai M, Akahane K, Inukai T, Lee W, Kim H, Kim HN, Ahn SM, Park HW, Kim DW.   +19 more
europepmc   +1 more source

Nilotinib Versus Imatinib in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+ CML): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs). [PDF]

Cureus
Zafar F, Poombal F, Ashraf L, Shivakumar D, Wankhade D, Winayak R, Ali Malik GM, Mahapatra SS, G C S, Huynh T, Mylavarapu M.   +10 more
europepmc   +1 more source

A smart pill bottle and text messaging intervention for promoting medication adherence in patients with chronic myeloid leukemia: a pilot study of txt4 TKI. [PDF]

Support Care Cancer
Wen KY, Palmisiano N, Smith R, Slamon R, Keiffer G, Fidler C, Kasner M, Wilde L.   +7 more
europepmc   +1 more source

Machine learning driven dashboard for chronic myeloid leukemia prediction using protein sequences. [PDF]

PLoS One
Ahmad W, Shahzad AR, Amin MA, Bangyal WH, Alahmadi TJ, Khan SH.   +5 more
europepmc   +1 more source

<i>MiR-92a-1-5p</i> contributes to cellular proliferation and survival in chronic myeloid leukemia and its inhibition enhances imatinib efficacy. [PDF]

Noncoding RNA Res
Peters J, Bollaert E, Cloos AS, Claus M, Essaghir A, Lenglez S, Saussoy P, Dachy G, Autin P, Demoulin JB, Havelange V.   +10 more
europepmc   +1 more source

Histopathological Changes as a Predictor of Fatal Outcome in Patients With Drug‐Induced Liver Injury

Liver International, Volume 45, Issue 7, July 2025.
Sabine Weber, Franziska Erhardt, Jens Neumann, Julian Allgeier, Didem Saka, Nirali Donga, Izabel Mircheva, Rochell Balakumar, Christian M. Lange, Alexander L. Gerbes   +9 more
wiley   +1 more source

Natural course and biology of CML [PDF]

Annals of Hematology, 2015
Chronic myeloid leukaemia (CML) is a myeloproliferative disorder arising in the haemopoietic stem cell (HSC) compartment. This disease is characterised by a reciprocal t(9;22) chromosomal translocation, resulting in the formation of the Philadelphia (Ph) chromosome containing the BCR-ABL1 gene.
Bradley Chereda, J. Melo
semanticscholar   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

The interferon-alpha revival in CML

Annals of Hematology, 2015
Interferon-alpha (IFNα) was once the standard of frontline treatment for chronic myeloid leukemia (CML). Its pleiotropic mechanism of action in CML includes immune activation and specific targeting of CML stem cells. Early studies of IFNα in CML demonstrated that patients in chronic phase could attain extremely stable remissions, which correlated with ...
M. Talpaz, Jessica Mercer, R. Hehlmann
semanticscholar   +4 more sources